Free Trial

Seelos Therapeutics (SEEL) Insider Trading & Ownership

$1.33
-0.04 (-2.92%)
(As of 05/24/2024 ET)

Seelos Therapeutics (NASDAQ:SEEL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.40%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$66,170.40
Number Of
Insiders Selling
(Last 3 Years)
0
Get SEEL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Seelos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SEEL Insider Buying and Selling by Quarter

Seelos Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/1/2022Daniel J O'connorDirectorBuy66$146.40$9,662.40  
3/31/2022Raj MehraInsiderBuy277$204.00$56,508.00  
(Data available from 1/1/2013 forward)

SEEL Insider Trading Activity - Frequently Asked Questions

Who is on Seelos Therapeutics's Insider Roster?

The list of insiders at Seelos Therapeutics includes Daniel J O'connor, and Raj Mehra. Learn more on insiders at SEEL.

What percentage of Seelos Therapeutics stock is owned by insiders?

5.40% of Seelos Therapeutics stock is owned by insiders. Learn more on SEEL's insider holdings.

Which Seelos Therapeutics insiders have been buying company stock?

The following insider purchased SEEL shares in the last 24 months: Daniel J O'connor ($9,662.40).

How much insider buying is happening at Seelos Therapeutics?

Insiders have purchased a total of 66 SEEL shares in the last 24 months for a total of $9,662.40 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:SEEL) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners